Top diabetes drugs in the United States based on revenue in 2011-2012 (in million U.S. dollars)

This statistic represents the top diabetes drugs in the United States, based on revenue between July 2011 and June 2012. In this period, diabetes drug Actos generated around 2.7 billion U.S. dollars of revenues.

Download this statistic as XLS, PNG and PDF?
Basic Account
  • Access to basic statistics (approx. 7%)
  • Download as XLS, PNG and PDF
Premium Account
$49per month*
  • All the advantages of the Basic Account
  • Instant access to all statistics
  • Easy integration into your projects
 Revenue in million U.S. dollars
Actos 2,736.4
Januvia 2,323.8
Lantus 2,064.7
Lantus Solostar 1,773.3
Novolog 1,073.7
Humalog 1,004.1
Levemir 947.8
Novolog Flexpen 897
Janumet 841.2
Victoza 3-Pak 587.9
Everything you need to know about...
Top pharmaceutical drugs - Statista Dossier
  • Great time-saver
  • All relevant statistics included

Offer: Order your Premium Account now & and get this dossier for free.

Get free dossier
Related market forecasts
Recommended studies and dossiers
Health & Pharmaceuticals - Statistics & Facts

Find the proper statistic fast and easy: